O'Dowd et al. [15] indicated that preoperative CRP more than 34 mg/L (HR = 1.65, 95% CI = 1.12–3.87, P = 0.045) retained independent significance of poor outcome in ninety-six lung cancer patients. The gene discussed is CRP; the disease is lung carcinoma.